Community/Retail

Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses how pharmacists can prepare themselves and their business before, during, and after a disaster.

Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, talks about some new transactions available that can help pharmacists.

Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.

In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.

Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.

Chlamydia, gonorrhea, and syphilis are on the rise for the first time since 2006, according to the US Centers for Disease Control and Prevention.

Skipping a flu shot may put patients at greater risk for flu-related pneumonia.

This weekly video program highlights the latest in pharmacy news, product news, and more.

Mylan has launched a generic version of Teva Pharmaceuticals' Adderall in 5 mg, 7.5 mg, 10 mg, 12.5 mg, 20 mg, and 30 mg doses.

The FDA has approved Boehringer Ingelheim's oral direct thrombin inhibitor dabigatran etexilate mesylate (Pradaxa) for the prophylaxis of deep vein thrombosis and pulmonary embolism in patients who have had hip replacement surgery.

As a result of implementation difficulties, the FDA announced that it will extend the pharmacy certification deadline for the clozapine risk evaluation and mitigation strategy program.

Few technicians enter the pharmacy profession with aspirations of working as translators, but many find themselves playing that role the moment they step behind the drop-off counter.

Having trouble getting your hands on FluMist?

One of the most common questions I am asked as a pharmacist is how to convert from one anticoagulant to another.

What you eat and drink on Thanksgiving can significantly affect some medications.

Novartis is paying $390 million to settle charges that it paid kickbacks to pharmacies to encourage drug sales.

Anxiety sensitivity has been linked to more debilitating asthma symptoms and greater functional limitations.

Nasal corticosteroid sprays do not seem to be viable treatments for the common cold.

Losing weight can help decrease the recurrence of atrial fibrillation in overweight patients.

The Advisory Committee on Immunization Practices recently updated the recommended interval between the 13-valeant pneumococcal conjugate vaccine and the 23-valeant pneumococcal polysaccharide vaccine in low-risk elderly patients.

Driving under the influence of prescription drugs may be just as dangerous as driving under the influence of alcohol.

Retrospective drug utilization review programs can reduce potentially unsafe concomitant opioid and central nervous system (CNS) medication use.

Carlos Aquino, founder and president of PharmaDiversion LLC, discusses timing of inspections from the Drug Enforcement Administration.

The FDA has again rejected AMAG Pharmaceuticals' application for a single-dose version of hydroxyprogesterone caproate injection (Makena) to reduce the risk of preterm birth for at-risk women.

More evidence is needed to figure out how to dose vancomycin in obese patients, but a new protocol could play a role.

There are many significant educational benefits of residency training that are supported by a number of pharmacy organizations, but there are a few you may not find in official literature.

While I was getting changed after a workout at the local YMCA, a familiar face got my attention.

You may not know who Albert Mehrabian, PhD, is, but you should at least be familiar with his work on communication.